FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14125011000001100: Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50148301000001116 Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
50148401000001112 Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Is a Mirtazapine 45mg orodispersible tablets true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Has active ingredient Mirtazapine true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Has manufactured dose form Conventional release oral lyophilisate false Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Has specific active ingredient Mirtazapine true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Has manufactured dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) 30 tablet Is pack of False Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) 30 tablet Has AMP True Mirtazapine 45mg orodispersible tablets (Consilient Health Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start